Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Many report fewer symptoms as their body adjusts
By helping patients feel fuller longer and reducing cravings, this therapy can support healthier eating habits and sustainable weight management when combined with proper nutrition and lifestyle choices.* The sublingual delivery system is designed for absorption under the tongue, offering a simple and approachable option for patients seeking an alternative to injectable therapies
Systemic GLP1RA injections lead to a distributed network of neuronal activation of regionssuch as parabrachial nucleus (PBN), central amygdala (CeA), area postrema (AP), nucleus of the solitary tract (NTS), bed nucleus of the stria terminalis (BNST)implicated in central appetite regulation 1013
GLP-1R Antagonist 1 Based on 7 publication(s) in Google Scholar GLP-1R Antagonist 1 (compound 5d) is an orally active, CNS penetrant and non-competitive antagonist of glucagon-like peptide 1 receptor (GLP-1R) , with an IC 50 of 650 nM
Sufficient time will be given before written informed consent is obtained by the investigators
N Engl J Med 2021;384(12):111324
US$ 23.43
US$ 20.35
US$ 21.44
US$ 24.77
US$ 25.62
